WO2016168741A3 - Detection of human cytomegalovirus - Google Patents

Detection of human cytomegalovirus Download PDF

Info

Publication number
WO2016168741A3
WO2016168741A3 PCT/US2016/027948 US2016027948W WO2016168741A3 WO 2016168741 A3 WO2016168741 A3 WO 2016168741A3 US 2016027948 W US2016027948 W US 2016027948W WO 2016168741 A3 WO2016168741 A3 WO 2016168741A3
Authority
WO
WIPO (PCT)
Prior art keywords
detection
human cytomegalovirus
hcmv
cmvil
seronegative
Prior art date
Application number
PCT/US2016/027948
Other languages
French (fr)
Other versions
WO2016168741A8 (en
WO2016168741A2 (en
Inventor
Juliet V. Spencer
Vivian Poi YOUNG
Original Assignee
Spencer Juliet V
Young Vivian Poi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spencer Juliet V, Young Vivian Poi filed Critical Spencer Juliet V
Publication of WO2016168741A2 publication Critical patent/WO2016168741A2/en
Publication of WO2016168741A8 publication Critical patent/WO2016168741A8/en
Publication of WO2016168741A3 publication Critical patent/WO2016168741A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

Provided herein, inter alia, are methods for detection of human cytomegalovirus (HCMV) infection in biological samples provided by individuals who are seronegative for antibodies to HCMV via assaying for the presence of the HCMV-encoded viral interleukin-10 (cmvIL-10) mRNA or protein.
PCT/US2016/027948 2015-04-16 2016-04-15 Detection of human cytomegalovirus WO2016168741A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562148629P 2015-04-16 2015-04-16
US62/148,629 2015-04-16

Publications (3)

Publication Number Publication Date
WO2016168741A2 WO2016168741A2 (en) 2016-10-20
WO2016168741A8 WO2016168741A8 (en) 2016-11-24
WO2016168741A3 true WO2016168741A3 (en) 2016-12-29

Family

ID=57126379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/027948 WO2016168741A2 (en) 2015-04-16 2016-04-15 Detection of human cytomegalovirus

Country Status (1)

Country Link
WO (1) WO2016168741A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019232453A1 (en) * 2018-06-01 2019-12-05 Gravid Therapies, Inc. Methods, kits, and products for detection of cytomegalovirus infection
WO2020108735A1 (en) * 2018-11-26 2020-06-04 Blink Biomedical Sas Antibodies to cytomegalovirus interleukin-10

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692954B1 (en) * 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US20120134957A1 (en) * 2003-11-28 2012-05-31 The University Of Syndey Latent phase viral interleukin-10-(vii-10) and uses thereof
US20140099299A1 (en) * 2011-03-29 2014-04-10 Uab Research Foundation Methods and Compositions for Cytomegalovirus IL-10 Protein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692954B1 (en) * 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US20120134957A1 (en) * 2003-11-28 2012-05-31 The University Of Syndey Latent phase viral interleukin-10-(vii-10) and uses thereof
US20140099299A1 (en) * 2011-03-29 2014-04-10 Uab Research Foundation Methods and Compositions for Cytomegalovirus IL-10 Protein

Also Published As

Publication number Publication date
WO2016168741A8 (en) 2016-11-24
WO2016168741A2 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
HK1243207A1 (en) Methods and systems for classifying biological samples, including optimization of analyses and use of correlation
MX2020009021A (en) Assays for detecting the presence or amount of an anti-drug antibody.
EP3924503A4 (en) Detection of human leukocyte antigen loss of heterozygosity
EA201792497A1 (en) ANTIBODIES TO GITR FOR DIAGNOSIS OF MALIGNANT TUMOR
WO2015200893A3 (en) Methods of analyzing nucleic acids from individual cells or cell populations
WO2017040930A3 (en) Biomarkers predictive of cytokine release syndrome
WO2014200910A3 (en) Bioinformatic processes for determination of peptide binding
WO2014107599A3 (en) Compositions and methods for detecting protease activity in biological systems
WO2011100749A3 (en) Methods and materials for detecting viral or microbial infections
WO2015176066A3 (en) Lpa-associated protein and rna expression
WO2016127077A8 (en) Systems and methods for detection and analysis of biological species
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
AU2017248682A1 (en) Method for detecting and/or characterising tumour cells and associated apparatus
EP3277831A4 (en) Biosensor system for the rapid detection of analytes
WO2016014612A3 (en) Compositions and methods for the diagnosis of rheumatoid arthritis
SG10201807572PA (en) Robust antibody purification
WO2015196192A3 (en) Methods and compositions relating to dengue virus
WO2016075546A3 (en) Antibodies that neutralize ebola virus and uses thereof
WO2016168741A8 (en) Detection of human cytomegalovirus
EP3406262A4 (en) Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection
WO2014039605A3 (en) Chimeric anti-dsdna/chromatin antibody
EP3869198A3 (en) Reagents and methods for breast cancer detection
WO2012089742A3 (en) IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
MX2017005650A (en) Antigen composition for detecting chagas disease.
WO2015200833A3 (en) COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16780933

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16780933

Country of ref document: EP

Kind code of ref document: A2